Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Promotion agreement established for wound-healing drugs

March 6, 1998

Cell adhesion inhibitors described by Kyowa Hakko

March 5, 1998

Vitamin D analogues with promising profile from Leo

March 3, 1998

Connetics' NDA for betamethasone mousse accepted by FDA

Feb. 27, 1998

Strengthened safety labeling for Accutane

Feb. 26, 1998

Safety and efficacy of tazarotene gel demonstrated in psoriasis

Feb. 26, 1998

Tazorac launched in Canada

Feb. 19, 1998

HGS's KGF-2 enters clinical testing

Feb. 13, 1998

Promising results with AlloDerm reported

Feb. 10, 1998

Celtrix and Genzyme expand collaboration

Feb. 10, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...